Outlook Therapeutics
OTLK
OTLK
81 hedge funds and large institutions have $6.11M invested in Outlook Therapeutics in 2023 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 25 increasing their positions, 19 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
88% less capital invested
Capital invested by funds: $51.1M → $6.11M (-$45M)
Holders
81
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$106K | |
| 2 | +$60.4K | |
| 3 | +$57K | |
| 4 |
BlackRock
New York
|
+$39.3K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$29.8K |
Top Sellers
| 1 | -$3.02M | |
| 2 | -$1.04M | |
| 3 | -$551K | |
| 4 |
Millennium Management
New York
|
-$250K |
| 5 |
MIM
MetLife Investment Management
Whippany,
New Jersey
|
-$145K |